Morrison & Foerster LLP advised Triastek, Inc. on the deal. Triastek, Inc., a leading pharmaceutical company specializing in 3D printing of drug products, announced its co-development...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here